secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cencora, Inc. (COR)
CIK:        0001140859
Form:       8-K
Filed at:   2023-05-02T23:59:59+00:00
Accession:  0001140859-23-000082
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AmerisourceBergen Q2 revenue $63.5B (+9.9%), adj EPS $3.50 (+8.7%), raises FY guidance
--------------------------------------------------------------------------------

- Revenue $63.5B, up 9.9% YoY; GAAP diluted EPS $2.13, adjusted $3.50 (up 8.7%).
- Adjusted diluted EPS guidance raised to $11.70-$11.90 from $11.50-$11.75 for FY2023.
- Announced agreement to invest in OneOncology; strategic capital deployment.
- Operating income: GAAP $561M, adjusted $932M; gross profit $2.3B GAAP, $2.4B adjusted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1140859/000114085923000082/0001140859-23-000082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1140859/000114085923000082/abc-20230502.htm
  HTML page:      https://secwatch.observer/filing/0001140859-23-000082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer